Riverview Trust Company’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.5K | Sell |
55
-194
| -78% | -$86.4K | 0.03% | 162 |
|
|
2025
Q1 | $121K | Sell |
249
-6
| -2% | -$2.91K | 0.12% | 137 |
|
|
2024
Q4 | $103K | Buy |
255
+1
| +0.4% | +$403 | 0.09% | 154 |
|
|
2024
Q3 | $118K | Buy |
254
+60
| +31% | +$27.9K | 0.1% | 151 |
|
|
2024
Q2 | $90.9K | Hold |
194
| – | – | 0.09% | 165 |
|
|
2024
Q1 | $81.1K | Buy |
+194
| New | +$81.1K | 0.06% | 185 |
|
|
2023
Q4 | – | Sell |
-194
| Closed | -$67.5K | – | 622 |
|
|
2023
Q3 | $67.5K | Hold |
194
| – | – | 0.06% | 198 |
|
|
2023
Q2 | $68.3K | Hold |
194
| – | – | 0.06% | 169 |
|
|
2023
Q1 | $61.1K | Hold |
194
| – | – | 0.06% | 182 |
|
|
2022
Q4 | $56K | Hold |
194
| – | – | 0.05% | 200 |
|
|
2022
Q3 | $56K | Hold |
194
| – | – | 0.05% | 188 |
|
|
2022
Q2 | $55K | Hold |
194
| – | – | 0.05% | 201 |
|
|
2022
Q1 | $51K | Buy |
+194
| New | +$51K | 0.04% | 222 |
|